Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development MA Tran, R Gowda, A Sharma, EJ Park, J Adair, M Kester, NB Smith, ... Cancer research 68 (18), 7638-7649, 2008 | 201 | 2008 |
Procoagulant activity of Calotropis gigantea latex associated with fibrin (ogen) olytic activity R Rajesh, CDR Gowda, A Nataraju, BL Dhananjaya, K Kemparaju, ... Toxicon 46 (1), 84-92, 2005 | 166 | 2005 |
Purification and characterization of a 34-kDa, heat stable glycoprotein from Synadenium grantii latex: action on human fibrinogen and fibrin clot R Rajesh, A Nataraju, CDR Gowda, BM Frey, FJ Frey, BS Vishwanath Biochimie 88 (10), 1313-1322, 2006 | 127 | 2006 |
Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial … HM Marriott, KA Gascoyne, R Gowda, I Geary, MJH Nicklin, F Iannelli, ... Infection and immunity 80 (3), 1140-1149, 2012 | 116 | 2012 |
Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia C Song, C Gowda, X Pan, Y Ding, Y Tong, BH Tan, H Wang, S Muthusami, ... Blood, The Journal of the American Society of Hematology 126 (15), 1813-1822, 2015 | 97 | 2015 |
Use of nanotechnology to develop multi-drug inhibitors for cancer therapy R Gowda, NR Jones, S Banerjee, GP Robertson Journal of nanomedicine & nanotechnology 4 (6), 2013 | 95 | 2013 |
Anticoagulant effect of Naja naja venom 5′ nucleotidase: demonstration through the use of novel specific inhibitor, vanillic acid BL Dhananjaya, A Nataraju, R Rajesh, CDR Gowda, BK Sharath, ... Toxicon 48 (4), 411-421, 2006 | 90 | 2006 |
Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport OF Kuzu, R Gowda, A Sharma, GP Robertson Molecular cancer therapeutics 13 (7), 1690-1703, 2014 | 76 | 2014 |
The role of exosomes in metastasis and progression of melanoma R Gowda, BM Robertson, S Iyer, J Barry, SS Dinavahi, GP Robertson Cancer Treatment Reviews 85, 101975, 2020 | 74 | 2020 |
Aldehyde dehydrogenase inhibitors for cancer therapeutics SS Dinavahi, CG Bazewicz, R Gowda, GP Robertson Trends in pharmacological sciences 40 (10), 774-789, 2019 | 74 | 2019 |
Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome S Ambatipudi, M Gerstung, R Gowda, P Pai, AM Borges, AA Schäffer, ... PloS one 6 (2), e17250, 2011 | 73 | 2011 |
Vanillic acid as a novel specific inhibitor of snake venom 5′-nucleotidase: a pharmacological tool in evaluating the role of the enzyme in snake envenomation BL Dhananjaya, A Nataraju, R Gowda, BK Sharath, CJM D’souza Biochemistry (moscow) 74 (12), 1315-1319, 2009 | 72 | 2009 |
Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanoma R Gowda, SRV Madhunapantula, D Desai, S Amin, GP Robertson Molecular cancer therapeutics 12 (1), 3-15, 2013 | 67 | 2013 |
Modulating cancer cell survival by targeting intracellular cholesterol transport OF Kuzu, R Gowda, MA Noory, GP Robertson British journal of cancer 117 (4), 513-524, 2017 | 64 | 2017 |
Nanoparticle-based celecoxib and plumbagin for the synergistic treatment of melanoma R Gowda, G Kardos, A Sharma, S Singh, GP Robertson Molecular cancer therapeutics 16 (3), 440-452, 2017 | 64 | 2017 |
Selenium-containing histone deacetylase inhibitors for melanoma management R Gowda, SRV Madhunapantula, D Desai, S Amin, GP Robertson Cancer biology & therapy 13 (9), 756-765, 2012 | 64 | 2012 |
Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule A Nataraj, CD Raghavendra Gowda, R Rajesh, BS Vishwanath Current Topics in Medicinal Chemistry 7 (8), 801-809, 2007 | 64 | 2007 |
Comparative study on plant latex proteases and their involvement in hemostasis: a special emphasis on clot inducing and dissolving properties R Rajesh, HV Shivaprasad, CD Gowda, A Nataraju, BL Dhananjaya, ... Planta Medica-Natural Products and Medicinal Plant Research 73 (10), 1061-1067, 2007 | 62 | 2007 |
Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy AK Brys, R Gowda, DB Loriaux, GP Robertson, PJ Mosca Biotechnology advances 34 (5), 565-577, 2016 | 58 | 2016 |
Targeting sphingosine kinase‐1 to inhibit melanoma SRV Madhunapantula, J Hengst, R Gowda, TE Fox, JK Yun, ... Pigment cell & melanoma research 25 (2), 259-274, 2012 | 57 | 2012 |